Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03816358
Brief Title: Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer

First Submitted : January 24, 2019
First Submitted that Met QC Criteria : January 24, 2019
First Posted : January 25, 2019

Last Update Submitted that Met QC Criteria : July 30, 2021
Last Update Posted : August 2, 2021 (Estimate)